People

Photo
12.01.2022 • News

Gelest Names Jonathan Goff as President

US chemicals and materials group Gelest has named Jonathan Goff as President effective immediately. He succeeds Barry Arkles, founder of Gelest, who has officially stepped down from his role as CEO on Dec. 31, 2021.

Photo
02.12.2021 • News

GSK Lures Pfizer’s Vaccines R&D Chief Away

Britain’s largest drugmaker, GlaxoSmithKline (GSK) has landed a major coup, luring Pfizer’s vaccines R&D chief away, as it tries to regain its position in the top tier of the vaccine league and build up its presence in the mRNA field. On Dec. 3, Philip Dormitzer, who had served as the US pharma giant’s chief scientific officer for RNA and viral vaccines since 2015, will say goodbye to New York and, figuratively, at least, hello to London.

Photo
17.02.2021 • News

PolyPeptide Group Appoints Raymond De Vré as new CEO

PolyPeptide Group has appointed Raymond De Vré as its new Chief Executive Officer (CEO). He will succeed Jane Salik who, after 15 years in this position, will concentrate on her role on the Board of Directors.

452 more articles

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.